Evidence map›Paper›PMID 32079590›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.

Niha Beig, Kaustav Bera, Prateek Prasanna, Jacob Antunes, Ramon Correa, Salendra Singh, Anas Saeed Bamashmos, Marwa Ismail, Nathaniel Braman, Ruchika Verma and 6 more

Open access · greenAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. MRI-based perfusion-diffusion habitat analysis for characterizing intratumoral heterogeneity in rectal adenocarcinoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Niha BeigCase Western Reserve University, Cleveland, Ohio.ORCID 0000-0002-1150-5886
Kaustav BeraCase Western Reserve University, Cleveland, Ohio.ORCID 0000-0001-9831-6000
Prateek PrasannaCase Western Reserve University, Cleveland, Ohio.
Jacob AntunesCase Western Reserve University, Cleveland, Ohio.
Ramon CorreaCase Western Reserve University, Cleveland, Ohio.
Salendra SinghCase Western Reserve University, Cleveland, Ohio.
Anas Saeed BamashmosCleveland Clinic, Cleveland, Ohio.
Marwa IsmailCase Western Reserve University, Cleveland, Ohio.
Nathaniel BramanCase Western Reserve University, Cleveland, Ohio.ORCID 0000-0001-5603-0821
Ruchika VermaCase Western Reserve University, Cleveland, Ohio.ORCID 0000-0003-4870-128X
Virginia B HillNorthwestern University Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0001-9146-9370
Volodymyr StatsevychCleveland Clinic, Cleveland, Ohio.
Manmeet S AhluwaliaCleveland Clinic, Cleveland, Ohio.
Vinay VaradanCase Western Reserve University, Cleveland, Ohio.
Anant MadabhushiCase Western Reserve University, Cleveland, Ohio.ORCID 0000-0002-5741-0399
Pallavi TiwariCase Western Reserve University, Cleveland, Ohio. pxt130@case.edu.
Case Western Reserve University · USCleveland Clinic · USLouis Stokes Cleveland VA Medical Center · USNorthwestern University · US

Funding

Role of MYC-MIZ1 signaling and the inflammatory immune microenvironment in Triple-Negative Breast Cancer Racial DisparitiesP20CA233216 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LI, LI · 2018 to 2021
$3.6M
Software to facilitate multimode, multiscale fused data for Pathology and RadioloR01CA136535 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, MICHAEL D, MADABHUSHI, ANANT · 2009 to 2013
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
Computational Genomic Epidemiology of Cancer (CoGEC) Training ProgramT32CA094186 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Thomas Louis LaFramboise, Rong Xu · 2017 to 2026
$2.6M
HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0M
Systems biology frameworks to unravel mechanisms driving complex disordersK25DK115904 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI VARADAN, VINAY · 2019 to 2021
$515k
Decision Support System for Predicting outcome of ER+ breast cancersR43EB015199 · NIBIB · IBRIS, INC. · PI GANESAN, SHRIDAR, HARDING, DAVE · 2011 to 2011
$207k
RadIO: A Novel Radiomics Toolkit to Predict and Characterize Response to Immunotherapy in Stage III Non-Small Cell Lung CancerI01BX004121 · VA · VETERANS HEALTH ADMINISTRATION · PI Anant Madabhushi, Charles J Nock · 2019 to 2026
–
BLRD VA I01 BX004121NCI NIH HHS P20 CA233216NCI NIH HHS R01 CA136535NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS T32 CA094186NCI NIH HHS U01 CA239055NCI NIH HHS U24 CA199374NCRR NIH HHS C06 RR012463NIBIB NIH HHS R43 EB015199NIDDK NIH HHS K25 DK115904
6 · The paper itself

Abstract

purposeTo (i) create a survival risk score using radiomic features from the tumor habitat on routine MRI to predict progression-free survival (PFS) in glioblastoma and (ii) obtain a biological basis for these prognostic radiomic features, by studying their radiogenomic associations with molecular signaling pathways. EXPERIMENTAL

designTwo hundred three patients with pretreatment Gd-T1w, T2w, T2w-FLAIR MRI were obtained from 3 cohorts: The Cancer Imaging Archive (TCIA;

resultsTwenty-five radiomic features from the tumor habitat yielded the RRS. A combination of RRS with clinical (age and gender) and molecular features (MGMT and IDH status) resulted in a concordance index of 0.81 (

conclusionsOur findings suggest that prognostic radiomic features from routine Gd-T1w MRI may also be significantly associated with key biological processes that affect response to chemotherapy in GBM.

Indexed as

Gene Expression Regulation, NeoplasticMutationAdultAgedAged, 80 and overBiomarkers, TumorBrain NeoplasmsFemaleGlioblastomaHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedPrognosisRisk AssessmentBiomarkers, Tumor

Identifiers

PMID32079590
PMCPMC7165059
OpenAlexW3006883269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.